Ascend Advanced Therapies is a global cell and gene therapy CDMO with operations in the U.S., UK, France, and Germany. In strategic alliance with Advanced BioScience Laboratories (ABL), the company provides comprehensive services spanning cell line and process development, cGMP manufacturing of cell and virus banks, and clinical supply for protein therapeutics, vaccines, and viral vectors. Ascend also offers process and formulation development, analytical services, and regulatory support for advanced modalities.